Therapeutic Advances in Neurological Disorders: Sage Journals

Por um escritor misterioso
Last updated 15 junho 2024
Therapeutic Advances in Neurological Disorders: Sage Journals
Therapeutic Advances in Neurological Disorders: Sage Journals
Biomedicines, Free Full-Text
Therapeutic Advances in Neurological Disorders: Sage Journals
Peptide-metal nanohybrids (PMN): Promising entities for combating neurological maladies - ScienceDirect
Therapeutic Advances in Neurological Disorders: Sage Journals
Trends and Outcomes of Left Ventricular Assist Device Therapy: JACC Focus Seminar
Therapeutic Advances in Neurological Disorders: Sage Journals
Age-related brain atrophy is not a homogenous process: Different functional brain networks associate differentially with aging and blood factors
Therapeutic Advances in Neurological Disorders: Sage Journals
PDF) Nusinersen for spinal muscular atrophy
Therapeutic Advances in Neurological Disorders: Sage Journals
Neurodegeneration in Normal Brain Aging and Disease
Therapeutic Advances in Neurological Disorders: Sage Journals
Unveiling the neurotechnology landscape: scientific advancements innovations and major trends
Therapeutic Advances in Neurological Disorders: Sage Journals
Autism Spectrum Disorder - Child Neurology Foundation
Therapeutic Advances in Neurological Disorders: Sage Journals
Plants, Free Full-Text
Therapeutic Advances in Neurological Disorders: Sage Journals
Speech and Language Therapy for Acquired Central Dysgraphia in Neurological Patients: A Systematic Review to Describe and Identify Trainings for Clinical Practice
Therapeutic Advances in Neurological Disorders: Sage Journals
Therapeutic Advances in Neurological Disorders: Sage Journals
Therapeutic Advances in Neurological Disorders: Sage Journals
Therapeutic Advances in Neurological Disorders: Sage Journals
Therapeutic Advances in Neurological Disorders: Sage Journals
Respiratory disorders of Parkinson's disease
Therapeutic Advances in Neurological Disorders: Sage Journals
Therapeutic Advances in Neurological Disorders
Therapeutic Advances in Neurological Disorders: Sage Journals
PDF) An epidemiological study on the course of disease and therapeutic considerations in relapsing–remitting multiple sclerosis patients receiving injectable first-line disease-modifying therapies in Germany (EPIDEM)

© 2014-2024 praharacademy.in. All rights reserved.